Rare diseases
Investigational molecules
Locations
Back to the Netherlands1 940 clinical trials in Hoofddorp, The Netherlands across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in the NetherlandsKlinischOnderzoek.nl(opens in a new tab)Study on MaaT033 to Prevent Complications in Patients with Blood Cancer Undergoing Stem Cell Transplantation
The NetherlandsStudy of Pembrolizumab for Children with Advanced Melanoma or PD-L1 Positive Solid Tumors and Lymphoma
The NetherlandsStudy of ONC201 for Patients with Newly Diagnosed H3 K27M-mutant Diffuse Glioma After Radiotherapy
The NetherlandsStudy Comparing Trastuzumab Deruxtecan with Standard Treatment for Patients with HER2-positive Breast Cancer
The NetherlandsStudy on Ivosidenib for Patients with Previously Treated Advanced or Metastatic Cholangiocarcinoma
The NetherlandsStudy on Durvalumab for Patients with High-Risk Endometrial Cancer After Surgery
The NetherlandsStudy of Lutetium (177Lu) Oxodotreotide for Children with Relapsed or Refractory High-Risk Neuroblastoma
The NetherlandsStudy on Fazirsiran for Patients with Alpha-1 Antitrypsin Deficiency-Related Liver Disease and Fibrosis
The NetherlandsStudy on Meniere's Disease: Comparing Methylprednisolone and Placebo for Patients with Unilateral Meniere's Disease
The NetherlandsStudy on Continuing Somatostatin Analogues with Sunitinib, Octreotide, and Lutetium (177Lu) Oxodotreotide for Patients with Neuroendocrine Tumors
The NetherlandsStudy on Hydrochlorothiazide and Tolvaptan for Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD)
The NetherlandsStudy on Long-Term Safety and Effectiveness of Vanzacaftor, Tezacaftor, and Deutivacaftor for Cystic Fibrosis in Patients Aged 1 Year and Older
The NetherlandsThe busiest research cities in the country
What the registry says about research in the country
Extensive research focusing on various cancer types including breast cancer, bladder cancer, and melanoma. Studies are evaluating novel treatment combinations and maintenance therapies for improved patient outcomes.
Multiple trials are investigating innovative approaches for both solid tumors and blood cancers, with particular emphasis on targeted therapies.
Comprehensive studies examining treatments for various blood disorders, including chronic myeloid leukemia, myelofibrosis, and lymphomas. Focus on developing targeted therapies and combination treatments.
Research aims to improve treatment outcomes and quality of life for patients with blood disorders.
Research initiatives addressing obesity management and surgical conditions like appendicitis. Studies include weight management therapies and surgical technique improvements.
Trials focus on both therapeutic and surgical interventions for better patient outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
